Evoke Pharma Inc reports results for the quarter ended in September - Earnings Summary

Evoke Pharma

11/11/2021 04:47

* Evoke Pharma Inc  EVOK.OQ  reported a quarterly adjusted loss
of 6 cents​​ per share for the quarter ended in September. The
lone analyst forecast for the quarter was for a loss of 7 cents
per share.
* Revenue was $930.00 thousand​;  analysts expected $382.00
thousand. 
* Evoke Pharma Inc's reported EPS for the quarter was a loss
of 6 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Evoke Pharma Inc shares had fallen by 6.9% this quarter and
lost 53.1% so far this year.
* The company reported a quarterly loss of $1.97 million.
* Wall Street's median 12-month price target for Evoke Pharma
Inc is $9.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 04:47 a.m.
 ​All figures in US dollars unless otherwise stated